DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,324,000 | +25.2% | 13,141 | -2.0% | 4.07% | +3.2% |
| Q1 2020 | $1,856,000 | -18.2% | 13,412 | -9.3% | 3.94% | +4.7% |
| Q4 2019 | $2,270,000 | +3.6% | 14,787 | -2.6% | 3.76% | -3.6% |
| Q3 2019 | $2,192,000 | -8.9% | 15,179 | -9.8% | 3.90% | +7.7% |
| Q2 2019 | $2,405,000 | +4.5% | 16,822 | -3.6% | 3.62% | +1.1% |
| Q1 2019 | $2,302,000 | +27.2% | 17,443 | -0.7% | 3.59% | +11.0% |
| Q4 2018 | $1,810,000 | -5.5% | 17,558 | -0.4% | 3.23% | +9.4% |
| Q3 2018 | $1,915,000 | +5.0% | 17,622 | -4.6% | 2.95% | +1.3% |
| Q2 2018 | $1,823,000 | +1.5% | 18,470 | +0.6% | 2.92% | +1.9% |
| Q1 2018 | $1,796,000 | +5.3% | 18,352 | -0.2% | 2.86% | +14.8% |
| Q4 2017 | $1,706,000 | +4.7% | 18,388 | -3.1% | 2.49% | +16.7% |
| Q3 2017 | $1,629,000 | +4.6% | 18,984 | +3.0% | 2.14% | +1.8% |
| Q2 2017 | $1,557,000 | +4.2% | 18,434 | +5.6% | 2.10% | -1.0% |
| Q1 2017 | $1,494,000 | +25.4% | 17,455 | +14.2% | 2.12% | +19.4% |
| Q4 2016 | $1,191,000 | +45.6% | 15,290 | +46.3% | 1.78% | +54.8% |
| Q3 2016 | $818,000 | +4.3% | 10,451 | +34.5% | 1.15% | +4.8% |
| Q2 2016 | $784,000 | +89.4% | 7,771 | +78.5% | 1.09% | +87.7% |
| Q1 2016 | $414,000 | – | 4,354 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |